Morning versus evening amlodipine treatment: Effect on circadian blood pressure profile in essential hypertensive patients

Blood Pressure Monitoring

Volumn 3, Issue 1, 1998, Pages 17-25

  Nold, Gudrun ^a   Strobel, Gudrun ^a   Lemmer, Björn ^a,b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b MEDICAL FACULTY MANNHEIM HEIDELBERG UNIVERSITY   (Germany)

Author keywords

Ambulatory blood pressure monitoring; Amlodipine; Essential hypertensive patients; Morning blood pressure rise; Morning versus evening

Indexed keywords

AMLODIPINE BESYLATE; ANTIHYPERTENSIVE AGENT;

ADULT; AGED; AMBULATORY MONITORING; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE MONITORING; CARDIOVASCULAR RISK; CIRCADIAN RHYTHM; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIASTOLIC BLOOD PRESSURE; DOSE TIME EFFECT RELATION; ESSENTIAL HYPERTENSION; FEMALE; HEART RATE; HUMAN; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC BLOOD PRESSURE;

EID: 0031920374     PISSN: 13595237     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Broadhurst P, Heber ME, Brigden G, Al-Khawaja I, Raftery EB. Intra-arterial monitoring of the antihypertensive effects of once-daily amlodipine. J Hum Hypertens 1992; 6 (suppl 1):S9-S12.
2. Burris JF, Allenby KS, Mroczek WJ. The effect of amlodipine on ambulatory blood pressure in hypertensive patients. Am J Cardiol 1994; 73:39A-43A.
3. Høegholm A, Wiinberg N, Rasmussen E, Nielsen PE, and a Danish Multicentre Group. Office and ambulatory blood pressure: a comparison between amlodipine and felodipine ER. J Hum Hypertens 1995; 9:611-616.
4. Navarro Estrada JL, Olivieri R. Long-term efficacy of amlodipine in patients with severe coronary artery disease. J Cardiovasc Pharmacol 1993; 22 (suppl A):S24-S28.
5. Lichtlen PR. Therapeutic options with the long-acting calcium antagonist amlodipine: results of the CAPE Study. J Cardiovasc Pharmacol 1994; 24 (suppl B):S21-S30.
6. Murdoch D, Heel RC. Amlodipine: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in cardiovascular disease. Drugs 1991; 41:478-505.
7. Meredith PA, Elliott HL. Clinical pharmacokinetics of amlodipine. Clin Pharmacokinet 1992; 22:22-31.
8. Hernández-Hernández R, Armas de Hernández MJ, Armas-Padilla MC, Carvajal AR, Guerrero-Pajuelo J. The effects of missing a dose of enalapril versus amlodipine on ambulatory blood pressure. Blood Pressure Monitoring 1996; 1:121-126.
9. Willich SN, Levy D, Rocco MB, Tofler GH, Stone PH, Muller JE. Circadian variation in the incidence of sudden cardiac death in the Framingham Heart Study population. Am J Cardiol 1987; 60:801-806.
10. Rocco MB, Barry J, Campbell S, Nabel E, Cook EF, Goldman L, et al. Circadian variation of transient myocardial ischemia in patients with coronary artery disease. Circulation 1987; 75:395-400.
11. Mulcahy D, Keegan J, Cunningham D, Quyyumi A, Crean P, Park A, et al. Circadian variation of total ischaemic burden and its alteration with antianginal agents. Lancet 1988; ii:755-759.
12. Muller JE, Stone PH, Tun ZG, Rutherford JG, Czeisler CA, Parkers C, et al. Circadian variation in the frequency of onset of acute myocardial infarction. N Engl J Med 1985; 313:1315-1322.
13. Toni D, Argentino C, Gentile M, Sacchetti ML, Girmenia F, Millfiorini E, et al. Circadian variation in the onset of acute cerebral ischemia: ethiopathogenetic correlates in 80 patients given angiography. Chronobiol Int 1991; 8:321-326.
14. Beilin LJ, Deacon J, Michael CA, Vandongen R, Lalor CM, Barden AE, et al. Diurnal rhythms of blood pressure, plasma renin activity, angiotensin II and catecholamines in normotensive and hypertensive pregnancies. Clin Exp Hypertens [B] 1983; 2:271-293.
15. Tofler GH, Brezinski D, Schafer AI, Czeisler CA, Rutherford JD, Willich SN, et al. Concurrent morning increase in platelet aggregability and the risk of myocardial infarction and sudden cardiac death. N Engl J Med 1987; 316:1514-1518.
16. Lemmer B, Brühl T, Pflug B, Köhler W, Touitou Y. Effects of bright light on circadian patterns of cAMP, melatonin and cortisol in healthy subjects. Eur J Endocrinol 1994; 130:472-477.
17. Panza JA, Epstein SE, Quyyumi AA. Circadian variation in vascular tone and its relation to α-sympathetic vasoconstrictor activity. N Engl J Med 1991; 325:986-990.
18. Ridker PM, Willich SN, Muller JE, Hennekens CH. Aspirin, platelet aggregation, and the circadian variation of acute thrombotic events. Chronobiol Int 1991; 8:327-335.
19. Andreotti F, Kluft C. Circadian variation of fibrinolytic activity in blood. Chronobiol Int 1991; 8:336-351.
20. Millar-Craig M, Bishop CN, Raftery EB. Circadian variation of blood pressure. Lancet 1978; i:795-797.
21. Lemmer B. Chronopharmacology of hypertension. Ann NY Acad Sci 1996; 783:242-253.
22. Lemmer B. Circadian rhythm in blood pressure: signal transduction, regulatory mechanisms and cardiovascular medication. In: Lemmer B (editor): From the biological clock to chronopharmacology. Stuttgart: medpharm Scientific Publishers; 1996. pp. 91-117.
23. Lemmer B: Differential effects of antihypertensive drugs on circadian rhythm in blood pressure from the chronobiological point of view. Blood Pressure Monitoring 1996; 1:161-169.
24. Lemmer B, Portaluppi F: Chronopharmacology of cardiovascular disease. In: Redfern PH, Lemmer B (editors) Physiology and pharmacology of biological rhythms. Heidelberg: Springer; 1997. pp. 251-297.
25. Zuther P, Witte K, Lemmer B. ABPM-FIT and CV-SORT: an easy-to-use software package for detailed analysis of data from ambulatory blood pressure monitoring. Blood Pressure Monitoring 1996; 1:347-354.
26. German Hypertension League: Statement on ambulatory blood pressure monitoring by the German Hypertension League. J Hum Hypertens 1995; 9:777-779.
27. O'Brien E, Mee F, Atkins N, O'Malley K. Accuracy of the SpaceLabs 90207 determined by the British Hypertension Society Protocol. J Hypertens 1991; 9 (suppl 5):S25-S31.
28. Groppelli A, Omboni S, Parati G, Mancia G. Evaluation of non-invasive blood pressure devices SpaceLabs 90202 and 90207 versus resting and 24-hour intra-arterial blood pressure. Hypertension 1992; 20: 227-232.
29. Ackerman H: BiAS. Biometrische Analyse von Stichproben. 5th edn. Darmstadt: Epsilon Verlag Hochheim; 1995.
30. Mengden T, Binswanger B, Spühler T, Weisser B, Vetter W. The use of self-measured blood pressure determinations in assessing dynamics of drug compliance in a study with amlodipine once a day, morning versus evening. J Hypertens 1993; 11:1403-1411.
31. Palatini P, Penzo M, Guzzardi G, Anaclerio M, Pessina AC. Ambulatory blood pressure monitoring in the assessment of antihypertensive treatment: 24-h blood pressure control with lacidipine once a day. J Hypertens 1991; 9 (suppl 3):S61-S66.
32. Zanchetti A, on behalf of the Italian Nifedipine Gastrointestinal Therapeutic System Study Group. The 24-hour efficacy of a new once-daily formulation of nifedipine. Drugs 1994; 48 (suppl 1):23-31.
33. Pieri R, Macchiarulo C, Merlo M, Pirrelli A. Effects of amlodipine once-daily administration on blood pressure circadian profiles evaluated by noninvasive 24-hour ambulatory blood pressure monitoring: inferential analysis of an open noncomparative study. Curr Ther Res 1994; 55:172-183.
34. Fogari R, Malacco E, Tettamanti F, Gnemmi AE, Milani M. Evening vs morning isradipme sustained-release in essential hypertension: a double-blind study with 24 h ambulatory monitoring. Br J Clin Pharmacol 1993; 35:51-54.
35. Greminger P, Suter PM, Holm D, Kobelt R, Vetter W. Morning versus evening administration of nifedipine gastrointestinal therapeutic system in the management of essential hypertension. Clin Invest 1994; 72:864-869.
36. Meilhac B, Mallion JM, Carre A, Chanudet X, Poggi L, Gosse P, et al. Étude de l'influence de l'horaire de la prise sur l'effet antihypertenseur et la tolérance de la nitrendipine chez des patients hypertendus essentiels légers à modérés. Therapie 1992; 47:205-210.
37. Kario K, Shimada K. Differential effects of amlodipine on ambulatory blood pressure in elderly hypertensive patients with different nocturnal reductions in blood pressure. Am J Hypertens 1997; 10:261-268.
38. Pierdomenico SD, Lapenna D, Cuccurullo F, Mezzatti A. Nighttime blood pressure pattern and myocardial ischaemia in hypertensive patients with coronary artery disease [abstract]. J Hypertens 1996: 14 (suppl 1):S249.
39. Imai Y, Abe K. Clinical significance of nocturnal blood pressure in the elderly. Cardiol Elderly 1993, 1:483-489.
40. Portaluppi F, Vergnani L, Manfredini R, degli Uberli EC, Fersini C. Time dependent effect of isradipine on the nocturnal hypertension of chronic renal failure. Am J Hypertens 1995; 8:719-726.